ABSTRACT NUMBER: ESOC2026A794 DIFFERENTIAL PROGNOSTIC VALUE OF CIRCULATING BIOMARKERS ACROSS SMALL ISCHEMIC STROKE SUBTYPES

Abstract Background and aims Circulating biomarkers reflecting inflammation and endothelial dysfunction have been proposed as indicators of cerebral small vessel disease. Still, their relevance during the hyperacute phase of ischemic stroke, not only in small vessel disease, remains uncertain. In this study we examine whether circulating biomarker profiles measured on admission differ between in patients with recent small subcortical infarcts (RSSI) and small cortical or cortico-subcortical stroke (non-RSSI), and whether they have prognostic value beyond conventional predictors. Methods Retrospective analysis of 168 patients with acute ischemic stroke treated with intravenous thrombolysis within 4.5 hours of onset. Patients were classified by magnetic resonance imaging as RSSI (n=84) or non-RSSI (n=84). Admission blood levels of interleukin-1β, interleukin-6, matrix metalloproteinase-9, vascular cell adhesion molecule-1, neurofilament light chain, C-reactive protein, and leukocyte count ratios were measured. Associations with 3-month functional outcomes (modified Rankin Scale) were evaluated using multivariable regression. Results RSSI patients were younger (66 vs. 74 years, p <0.001) and had smaller infarcts (median 0.68 vs. 2.55 mL, p<0.001). Neurofilament light chain (OR 2.07, p<0.001) and vascular cell adhesion molecule-1 (OR 1.84, p=0.034) predicted poorer outcomes in adjusted models. The prognostic value of C-reactive protein, matrix metalloproteinase-9, and VCAM-1 was more substantial in RSSI than in non-RSSI patients. Conclusions In RSSI, markers of inflammation and endothelial dysfunction improved outcome prediction, suggesting a role for microvascular pathology in recovery. The integration of biomarker profiling into early stroke assessment might help identify patients who could benefit from adjunctive therapies targeting microvascular dysfunction. Conflict of interest Dario Ramis: nothing to disclose.

Authors

Institutions

Publication Details

Journal
European Stroke Journal
Published
2026-05-01
DOI
https://doi.org/10.1093/esj/aakag023.432
Primary Topic
Neuroinflammation and Neurodegeneration Mechanisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ABSTRACT NUMBER: ESOC2026A794 DIFFERENTIAL PROGNOSTIC VALUE OF CIRCULATING BIOMARKERS ACROSS SMALL ISCHEMIC STROKE SUBTYPES

Arturo Renú, Martha Vargas, Alejandro Rodríguez Vázquez, Inés Bartolomé et al.
European Stroke Journal
Neuroinflammation and Neurodegeneration Mechanisms
article

ABSTRACT NUMBER: ESOC2026A794 DIFFERENTIAL PROGNOSTIC VALUE OF CIRCULATING BIOMARKERS ACROSS SMALL ISCHEMIC STROKE SUBTYPES

Arturo Renú, Martha Vargas, Alejandro Rodríguez Vázquez, Inés Bartolomé, Sergio Amaro, Salvatore Rudilosso, Andrea Cabero-Arnold, Andrés Girona, Darío Ramis, Antonio Doncel-Moriano, Xabier Urra, Angel Chamorro, Laura Llull, Irene Rosa Batlle, Ona Brengaret
article en

Abstract

Abstract Background and aims Circulating biomarkers reflecting inflammation and endothelial dysfunction have been proposed as indicators of cerebral small vessel disease. Still, their relevance during the hyperacute phase of ischemic stroke, not only in small vessel disease, remains uncertain. In this study we examine whether circulating biomarker profiles measured on admission differ between in patients with recent small subcortical infarcts (RSSI) and small cortical or cortico-subcortical stroke (non-RSSI), and whether they have prognostic value beyond conventional predictors. Methods Retrospective analysis of 168 patients with acute ischemic stroke treated with intravenous thrombolysis within 4.5 hours of onset. Patients were classified by magnetic resonance imaging as RSSI (n=84) or non-RSSI (n=84). Admission blood levels of interleukin-1β, interleukin-6, matrix metalloproteinase-9, vascular cell adhesion molecule-1, neurofilament light chain, C-reactive protein, and leukocyte count ratios were measured. Associations with 3-month functional outcomes (modified Rankin Scale) were evaluated using multivariable regression. Results RSSI patients were younger (66 vs. 74 years, p <0.001) and had smaller infarcts (median 0.68 vs. 2.55 mL, p<0.001). Neurofilament light chain (OR 2.07, p<0.001) and vascular cell adhesion molecule-1 (OR 1.84, p=0.034) predicted poorer outcomes in adjusted models. The prognostic value of C-reactive protein, matrix metalloproteinase-9, and VCAM-1 was more substantial in RSSI than in non-RSSI patients. Conclusions In RSSI, markers of inflammation and endothelial dysfunction improved outcome prediction, suggesting a role for microvascular pathology in recovery. The integration of biomarker profiling into early stroke assessment might help identify patients who could benefit from adjunctive therapies targeting microvascular dysfunction. Conflict of interest Dario Ramis: nothing to disclose.

European Stroke JournalVol. 11(Supplement_1)
Hospital Clínic de Barcelona (ES), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
Good health and well-being
Openalex Percentile: Top 9%
Neuroinflammation and Neurodegeneration Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.